a current southeastern cancer study group protocol for the treatment of multiple myeloma involves induction with bcnu , cyclophosphamide , and prednisone ( bcp ) and maintenance with either melphalan and prednisone ( mp ) , prednisone , adriamycin , imuran , and vincristine ( paiv ) , or delayed treatment of relapsed cases following induction .
C0026764
myeloma
C0007257
bcnu